aTyr Pharma, Inc. (ATYR) Tops Q2 EPS by 1c
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.
aTyr Pharma, Inc. (NASDAQ: ATYR) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12).
For earnings history and earnings-related data on aTyr Pharma, Inc. (ATYR) click here.